Item 8.01 Other Events. On June 22, 2026, Translational Development Acquisition Corp. (the “Company” or “TDAC”) issued a press release announcing certain results of shareholder redemptions in connection with the shareholder vote held on June 17, 2026 regarding the extension of the deadline by which TDAC must consummate an initial business combination and providing certain information regarding TDA…
Filed Jun 23, 2026Accepted Jun 23, 2026, 10:18 AM EDTCIK 1926599Accession 0001104659-26-076684
The Company is a blank check company incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business, industry, sector, or geographical location, and intends to focus on industries that complement its management team's background, and intends to capitalize on the ability of its management team to identify and acquire a business.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On June 22, 2026, Translational Development Acquisition Corp. (the
“Company” or “TDAC”) issued a press release announcing certain results of shareholder redemptions in connection
with the shareholder vote held on June 17, 2026 regarding the extension of the deadline by which TDAC must consummate an initial business
combination and providing certain information regarding TDAC’s proposed business combination with ProLogium Holding Inc. A copy
of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
The information contained in this Current Report on Form 8-K, including
Exhibit 99.1, is being filed for purposes of Rule 425 under the Securities Act of 1933, as amended, and Rule 14a-12 under the Securities
Exchange Act of 1934, as amended.
Filed exhibits (1)
EX-99.1 (by filename) tm2618552d1_ex99-1.htm
EX-99.1
2
tm2618552d1_ex99-1.htm
EXHIBIT 99.1
Exhibit 99.1
TDAC Announces Very Successful Share Redemption Results in Connection
with Extension Vote
85% of Shares are not Redeemed, resulting in TDAC maintaining $156.8mm in trust
95% of the Shares Voted Were In Favor of the Extension
These Great Results Follow the Momentum of the May 27, 2026 announcement of TDAC’s Entry into a Merger Agreement with Prologium
───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
Prologium is a global leader in next generation lithium ceramic battery technology, moving into growth markets, including AI Data
Centers, aerospace, robotics, defense and electric vehicles
NEW YORK, NY - June 22,2026 - Translational
Development Acquisition Company (NYSE: TDAC) (the “Company” or “TDAC”) announced the very successful results of
the shareholder vote held on 6/17/26 regarding the proposed extension of the SPAC life and election of shareholders to redeem their shares
or continue to participate in TDAC.
In connection with the meeting, holders of the Company’s Class
A common stock were given the opportunity to redee…